Tested groups | Latency time (sec.) | Percentage increase in latency time |
Control | 10.17 ± 1.5 | ------------------ |
Indomethacin | 19.50 ± 3.5 | 91% |
Voltarin | 25.67 ± 5.3a | 152.4% |
1 | 19.83 ± 1.9 | 95% |
3a | 35.17 ± 7.3a | 245.8% |
3b | 17.67 ± 4.6 | 73.7% |
3c | 22.33 ± 7.4a | 119.6% |
5a | 35.5 ± 16.2a | 249% |
5b | 22.17 ± 10.8a | 118% |
5c | 31.50 ± 9.7a | 209.7% |
6 | 9 ± 2.5 | −11.5% |
7a | 28.83 ± 4.3a | 183.5% |
7b | 29.00 ± 6.2a | 185% |
7c | 29.67 ± 6.0a | 191.7% |
8 | 17.83 ± 5.2 | 75.3 |
9 | 13.00 ± 6.9 | 27.8% |
10 | 20.17 ± 7.4a | 98.3% |
11 | 26.50 ± 3.8a | 160.6% |
12 | 39.33 ± 6.0a | 286.7% |
13a | 17.83 ± 6.4 | 75.3% |
13b | 23.17 ± 11.9a | 127.8% |
13C | 36.17 ± 14.1a | 255.6% |
14a | 11.7 ± 4.4 | −15% |
14b | 33.17 ± 6.6a | 226% |
14c | 25.17 ± 10.9a | 147.5% |
15 | 21.57 ± 9.9a | 112% |
16 | 18.83 ± 4.3 | 85.15% |
17 | 10.00 ± 2.4 | −1.7% |